RegulatoryJul 24, 2026, 05:04 PM
MDxHealth Receives Nasdaq Delisting Warning for Market Value
AI Summary
MDxHealth SA announced it received an additional notification from Nasdaq regarding non-compliance with the minimum market value requirement of US$35 million. This follows a previous notification on July 2, 2026, for not meeting the $1.00 minimum bid price. The company has 180 calendar days, until January 19, 2027, to regain compliance by maintaining a market value above US$35 million for at least 10 consecutive business days. MDxHealth stated its business operations are not affected and it intends to cure the deficiency.
Key Highlights
- MDxHealth received Nasdaq notification for minimum market value deficiency.
- Nasdaq requires a minimum market value of US$35 million for continued listing.
- Deficiency occurred as market value was below US$35 million for 30 consecutive business days.
- Company has 180 calendar days, until January 19, 2027, to regain compliance.
- To regain compliance, market value must exceed US$35 million for 10 consecutive business days.
- Previously received notification on July 2, 2026, for $1.00 minimum bid price deficiency.
- Company intends to monitor market value and cure the deficiency within the grace period.
Price Impact
More from MDXH